Veterinary Medicines

VERSIFEL CVR-C

Not authorised
  • Feline panleucopenia virus, strain Snow Leopard, Live
  • Felid herpesvirus 1, strain FVRm, Live
  • Feline calicivirus, strain F9, Live
  • Water for injection
  • Chlamydia felis, strain Baker, Live
Download as PDF

Product identification

Medicine name:
VERSIFEL CVR-C
Active substance:
  • Feline panleucopenia virus, strain Snow Leopard, Live
  • Felid herpesvirus 1, strain FVRm, Live
  • Feline calicivirus, strain F9, Live
  • Water for injection
  • Chlamydia felis, strain Baker, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain Snow Leopard, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Felid herpesvirus 1, strain FVRm, Live
    5.00
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Feline calicivirus, strain F9, Live
    5.50
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
  • Water for injection
    1.00
    millilitre(s)
    /
    1.00
    unit(s)
  • Chlamydia felis, strain Baker, Live
    3.20
    log10 50% cell culture infectious dose
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AF01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/5495902 8/2009
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download